HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Previous close
€4.64
Day range
€4.62 - €4.86
Year range
€4.42 - €8.40
Market cap
131.04M EUR
Avg Volume
6.08K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.75M | 7.30% |
Operating expense | 4.71M | 26.75% |
Net income | -1.39M | 2.73% |
Net profit margin | -50.58 | 9.35% |
Earnings per share | — | — |
EBITDA | -1.78M | -70.65% |
Effective tax rate | 7.09% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.27M | -40.92% |
Total assets | 33.36M | -19.30% |
Total liabilities | 6.88M | -25.13% |
Total equity | 26.48M | — |
Shares outstanding | 27.73M | — |
Price to book | 4.88 | — |
Return on assets | -15.69% | — |
Return on capital | -18.63% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.39M | 2.73% |
Cash from operations | -1.83M | -2.90% |
Cash from investing | -406.00K | -539.37% |
Cash from financing | -133.00K | -67.30% |
Net change in cash | -2.42M | -26.17% |
Free cash flow | -1.52M | -183.52% |
About
Founded
2012
Website
Employees
50
